Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$191M |
| 2 |
Nike
NKE
|
+$190M |
| 3 |
UnitedHealth
UNH
|
+$158M |
| 4 |
Shopify
SHOP
|
+$153M |
| 5 |
TSMC
TSM
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$910M |
| 2 |
Microsoft
MSFT
|
+$668M |
| 3 |
Meta Platforms (Facebook)
META
|
+$351M |
| 4 |
Micron Technology
MU
|
+$244M |
| 5 |
Apple
AAPL
|
+$191M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.86% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 14.09% |
| 4 | Financials | 8.98% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Bitwise Bitcoin ETF
BITB
$2.41B
| $1.47M | ﹤0.01% |
+29,000
| New | +$1.31M |
|
2252
Civista Bancshares
CIVB
$593M
| $1.47M | ﹤0.01% |
70,065
-5,700
| -8% | -$118K |
|
2253
Caledonia Mining Corp
CMCL
$434M
| $1.47M | ﹤0.01% |
156,527
+82,927
| +113% | +$1.06M |
|
|
OGI
2254
Organigram Holdings
OGI
$173M
| $1.47M | ﹤0.01% |
914,648
+21,200
| +2% | +$34.5K |
|
2255
UroGen Pharma
URGN
$2.35B
| $1.47M | ﹤0.01% |
+138,200
| New | +$1.65M |
|
2256
Steel Dynamics
STLD
$36.7B
| $1.47M | ﹤0.01% |
12,900
-110,538
| -90% | -$14.7M |
|
2257
Quantum-Si Incorporated
QSI
$161M
| $1.47M | ﹤0.01% |
544,956
+503,400
| +1,211% | +$590K |
|
2258
Mineralys Therapeutics
MLYS
$2.27B
| $1.47M | ﹤0.01% |
119,500
+15,700
| +15% | +$205K |
|
2259
Elbit Systems
ESLT
$36.7B
| $1.47M | ﹤0.01% |
5,700
+400
| +8% | +$93.8K |
|
2260
Atossa Therapeutics
ATOS
$25.9M
| $1.47M | ﹤0.01% |
103,842
+16,504
| +19% | +$322K |
|
|
SLRN
2261
DELISTED
ACELYRIN
SLRN
| $1.47M | ﹤0.01% |
466,921
-67,897
| -13% | -$329K |
|
2262
Crown Crafts
CRWS
$30.7M
| $1.46M | ﹤0.01% |
326,241
-10,101
| -3% | -$46.7K |
|
2263
SES AI
SES
$223M
| $1.46M | ﹤0.01% |
665,300
+445,600
| +203% | +$254K |
|
|
AUTL
2264
Autolus Therapeutics
AUTL
$572M
| $1.45M | ﹤0.01% |
618,942
+368,071
| +147% | +$1.24M |
|
2265
iShares US Equity Factor ETF
LRGF
$3.74B
| $1.45M | ﹤0.01% |
24,100
+10,200
| +73% | +$620K |
|
2266
Phinia Inc
PHIN
$2.73B
| $1.45M | ﹤0.01% |
30,100
-23,300
| -44% | -$1.15M |
|
2267
Aware
AWRE
$26.4M
| $1.45M | ﹤0.01% |
741,973
-24,597
| -3% | -$41.9K |
|
|
CHMI
2268
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $1.45M | ﹤0.01% |
547,784
-131,528
| -19% | -$395K |
|
2269
ARK 21Shares Bitcoin ETF
ARKB
$2.4B
| $1.45M | ﹤0.01% |
+46,500
| New | +$1.28M |
|
2270
Horizon Bancorp
HBNC
$1.06B
| $1.45M | ﹤0.01% |
89,716
+33,000
| +58% | +$554K |
|
2271
COPT Defense Properties
CDP
$4.19B
| $1.44M | ﹤0.01% |
46,623
-135,777
| -74% | -$4.31M |
|
2272
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.17B
| $1.44M | ﹤0.01% |
19,100
+10,200
| +115% | +$780K |
|
2273
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.6B
| $1.44M | ﹤0.01% |
8,900
+4,700
| +112% | +$793K |
|
|
WHWK
2274
Whitehawk Therapeutics
WHWK
$254M
| $1.44M | ﹤0.01% |
456,022
-5,800
| -1% | -$13.1K |
|
2275
John Wiley & Sons Class A
WLY
$2.61B
| $1.44M | ﹤0.01% |
32,900
-50,200
| -60% | -$2.46M |
|
Similar funds
Jim Simons's Q4 2024 Portfolio in Review
As of Q4 2024, Jim Simons held 4,032 positions worth $67.6B, up 1.6% from $66.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Jim Simons's Q4 2024 filing shows 548 new, 1,485 increased, 1,480 reduced and 497 closed positions. Its largest new stake was UnitedHealth: 278,658 shares worth $141M. The largest sale was Palantir, an estimated $910M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q4 2024 buy was UnitedHealth: 278,658 shares worth $141M.
- Jim Simons added most to Alibaba in Q4 2024, an estimated $191M increase.
- Jim Simons's biggest Q4 2024 reduction was Palantir, cutting an estimated $910M.
- Jim Simons fully exited Arm in Q4 2024, selling an estimated $153M.
- Jim Simons's ten largest holdings make up 10% of its $67.6B portfolio in Q4 2024.
- Jim Simons opened 548 new positions and closed 497 in Q4 2024.
- Jim Simons's portfolio value rose 1.6% quarter-over-quarter to $67.6B.
Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.